Back to search

National and Kapodistrian University of Athens

Η αντισταθμιστική σωματική άσκηση ως θεραπευτικό εργαλείο για τη βελτίωση βιολογικών και ψυχολογικών παραμέτρων σε ασθενείς εξαρτημένους από οπιοειδή που βρίσκονται σε θεραπεία υποκατάστασης

Abstract

dc:description

Long-term adherence of patients to opioid substitution therapy is limited. Neurobiological and physiological changes induced by chronic opioid use disrupt many homeostatic systems, particularly those related to the perception of pleasure, hedonic reward, anxiety, and subsequent hedonic dysregulation. Some of these changes have been shown (in the general population as well as in small samples of individuals with substance use disorders) to be reversible through aerobic exercise. The hormones cortisol and β-endorphin appear to be influenced by physical exercise, acting as compensatory and regulatory factors for various psychological parameters, contributing to the balance of changes associated with opioid use. PURPOSE: The present study aimed to: (a) Investigate the effects of a supervised two-month moderate intensity aerobic exercise program on salivary β-endorphin and cortisol levels in opioid-dependent patients undergoing pharmacological substitution therapy. (b) Explore the potential impact of the proposed physical exercise protocol on concurrent use of non-opioid substances (e.g., alcohol, cocaine, cannabis, and benzodiazepines). (c) Examine the effect of exercise on the quality of life of these individuals, with an emphasis on physical and mental health, employment, education, homelessness, volunteering, violence, and criminal behavior. METHODOLOGY: Ninety opioid users (41 women) undergoing substitution therapy with methadone or buprenorphine in OKANA units were randomly divided into four groups: (a) Buprenorphine experimental group (BEG, n = 26, age 41.9 ± 6.1 years), (b) Buprenorphine control group (BCG, n = 25, age 41.9 ± 5.6 years), (c) Methadone experimental group (MEG, n = 20, age 46.7 ± 6.6 years), and (d) Methadone control group (MCG, n = 19, age 46.1 ± 7.5 years). The control groups received motivational education on the health benefits of physical exercise but did not follow an exercise program. The experimental groups (BEG and MEG) participated in an 8-week supervised aerobic treadmill program (20 minutes, 70% of maximum heart rate, 3 days/week). Hormonal variables cortisol and β-endorphin were assessed in all groups. Saliva samples were collected before exercise (BE) and immediately after exercise (AE) on three different intervention days (1st, 12th, and 24th session), representing the beginning, middle, and end of the exercise program. Approximately 2 mL of saliva was collected using special vials, and hormonal determinations were performed using the ELISA method. The "Treatment Outcomes Profile" (TOP) questionnaire was used to assess weekly alcohol, cocaine, cannabis, benzodiazepine, and other psychoactive substance consumption, as well as methadone and buprenorphine treatment frequency and quantity. The questionnaire was administered before, during, and after the exercise program (1st, 12th, and 24th exercise session). Finally, the TOP questionnaire was used to evaluate quality of life in terms of physical and mental health, employment, education, volunteering, housing, violent behavior, and criminal activity. Statistical analysis (SPSS) utilized non-parametric tests, including Two-way and One-way ANOVA. Pearson’s χ2 test or Fisher's exact test was used for ratio comparisons where necessary. Friedman’s test was employed to compare β-endorphin and cortisol levels across the three sessions, while Spearman’s rho correlation coefficient analyzed relationships between two quantitative variables. Multiple linear regression identified independent parameters related to quality-of-life dimensions. RESULTS: β endorphin: Significant differences in β-endorphin measurements were observed between exercise and control groups for both buprenorphine and methadone groups. Differences emerged post-exercise during the 1st session and both pre and post exercise during the 24th session (p<0.001), with the exercise groups showing significantly higher values (p<0.001). In the buprenorphine exercise group, β- endorphin levels at the 24th session were significantly higher compared to the 1st and 12th sessions (steady increase) (BEG pre: 63.8 ± 33, post: 185.6 ± 182.8 pg/mL, p<0.001). In the buprenorphine control group, levels increased during the 12th session but returned to baseline by the 24th session (BCG pre: 34.7 ± 20.1, post: 24.2 ± 8.8 pg/mL, p<0.001). Similarly, in the methadone group, β-endorphin levels steadily increased throughout the program, with statistical significance observed after the first month (MEG pre: 115 ± 211, post: 262.3 ± 505.7 pg/mL, p<0.001), while no significant changes were detected in the control group (MCG pre: 129.7 ± 185.7, post: 84.9 ± 104.3 pg/mL, p<0.001). Cortisol: Cortisol measurements showed significant differences between exercise and control groups for both buprenorphine and methadone. Differences were identified pre- and post-exercise during the 12th and 24th sessions, with the exercise groups recording significantly lower measurements compared to controls (p<0.001). In the buprenorphine exercise group, cortisol levels at the 24th session were significantly lower compared to the 1st and 12th sessions (steady decrease) (BEG pre: 9.5 ± 5.9, post: 2.8 ± 1.5 ng/mL, p<0.001). Treatment Outcomes Profile (TOP): Post-intervention, weekly alcohol consumption decreased in both exercise groups, with the buprenorphine exercise group showing lower levels (BEG pre: 2.62 ± 1.63, post: 1.42 ± 1.36) compared to methadone (MEG pre: 4.5 ± 1.67, post: 2.15 ± 1.6). Non-opioid substance use (e.g., cannabis, benzodiazepines, cocaine) significantly decreased in exercise groups, while control groups exhibited increases. Quality of life improved significantly across both substitution treatments, with greater improvements observed in exercise groups, especially with buprenorphine (F(2,98) = 102.50, p<0.001). Concerning individual histories, relapses and cocaine use negatively affected employment days (p<0.015), while amphetamine consumption during weeks 5–8 correlated with reduced education/training days (p<0.003). Methadone users displayed higher homelessness and violent behavior rates compared to buprenorphine users (p<0.001), while exercise groups had significantly lower rates than methadone control groups. DISCUSSION: In our study, consistent with existing literature, it was observed that during the first month of exercise, both β-endorphin and cortisol levels increased following a physical exercise program. However, after the first month, β-endorphin levels increased while cortisol levels decreased in experimental exercise groups, contrary to existing data. These changes may be associated with improved mood and reduced stress. Furthermore, this phenomenon possibly indicates that β-endorphin may act as a stress regulator by reducing cortisol levels. The proposed underlying mechanism involves the sequential activation of the endogenous endocannabinoid system, the mesolimbic dopaminergic reward system, and ultimately the stress system, driven by elevated β-endorphin levels. Moreover, regular physical exercise reduces the tendency for increased cortisol levels by activating the hippocampus-medial prefrontal cortex-amygdala neuronal circuit, leading to the inhibition of the hypothalamus and pituitary through receptors in the medial prefrontal cortex. It also mitigates amygdala hyperactivity induced by stress, thereby restoring homeostasis. These significant changes, not observed in the control groups, were mainly identified after the first month of the exercise protocol, highlighting the importance of long-term and systematic physical exercise. Notably, the dosage of the substitution treatment was significantly reduced during the final two weeks of the study exclusively in the exercise group receiving buprenorphine, a finding not previously reported. Additionally, exercise contributed to a reduction in the use of alcohol, cannabis, benzodiazepines, and cocaine, particularly among patients receiving buprenorphine, indicating the positive impact of exercise in cases of polysubstance use in substitution treatment settings. Our findings also suggest that exercise alleviates the negative effects of dependence on individuals’ occupational, educational, social, and psychosomatic well-being. Following the two-month intervention, improvements were observed in key domains such as employment, education, volunteer activity, housing, social stability, and unemployment, demonstrating that exercise may facilitate the social reintegration of individuals. This observation is supported by numerous other studies, showcasing the positive effects of systematic physical exercise on the quality of life of individuals with substance dependence. CONCLUSION: Aerobic exercise, potentially through neurohormonal changes, has a beneficial effect on patients with opioid use disorder undergoing substitution therapy, reinforcing the notion that exercise can serve as an effective therapeutic strategy. It may promote the adoption of a healthy lifestyle with immediate positive effects on the quality of life of these patients and possibly other vulnerable populations. This study has the following limitations: a) the need to confirm findings over a longer follow-up period, b) the relatively small sample size, c) problematic compliance with the saliva sampling protocol in certain cases, d) a broad assessment of quality of life, e) variability in physical fitness levels and overall lifestyle among participants, f) the possibility that participants in the exercise groups were already more motivated to engage in exercise programs, and g) all participants were receiving pharmacological treatment for opioid use disorder (OUD), limiting the generalizability of findings to other populations or individuals with OUD undergoing different treatments.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2025

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Psarianos, Alexandros
  • Ψαριανός, Αλέξανδρος

Subjects

dc:subject × 16

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/58781

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Psarianos, Alexandros; Ψαριανός, Αλέξανδρος. Η αντισταθμιστική σωματική άσκηση ως θεραπευτικό εργαλείο για τη βελτίωση βιολογικών και ψυχολογικών παραμέτρων σε ασθενείς εξαρτημένους από οπιοειδή που βρίσκονται σε θεραπεία υποκατάστασης. National and Kapodistrian University of Athens, 2025. http://hdl.handle.net/10442/hedi/58781